Stereochemistry | MIXED |
Molecular Formula | C23H32N2O3 |
Molecular Weight | 384.5118 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 0 / 3 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
COC(CN1CCN(CC(O)C(OC)C2=CC=CC=C2)CC1)C3=CC=CC=C3
InChI
InChIKey=VSTNNAYSCJQCQI-UHFFFAOYSA-N
InChI=1S/C23H32N2O3/c1-27-22(19-9-5-3-6-10-19)18-25-15-13-24(14-16-25)17-21(26)23(28-2)20-11-7-4-8-12-20/h3-12,21-23,26H,13-18H2,1-2H3
Molecular Formula | C23H32N2O3 |
Molecular Weight | 384.5118 |
Charge | 0 |
Count |
MOL RATIO
1 MOL RATIO (average) |
Stereochemistry | MIXED |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 3 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Zipeprol is disubstituted piperazine that is marketed as a non-opioid antitussive in Europe, Asia, and South America. Zipeprol is not available in the United States or Canada and has been discontinued in Europe. Zipeprol is still available in some countries in Asia and South America. Zipeprol was demonstrated to have anticough effects in animal models, to be active as a blocker of histamine and cholinergic function, to be a potent local anesthetic and to possess bronchiospasmolytic actions. it had no remarkable cardiovascular or gastrointestinal actions in the rat or dog in comparison to codeine.